Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
A Review of Psychopharmacological Interventions Post-Disaster to Prevent Psychiatric Sequelae
1
x
$
30.00
Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies
1
x
$
30.00
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder
1
x
$
0.00
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
1
x
$
0.00
The Addition of Amphetamine to Potentially Sedating Medication Regimens: An Exploratory Investigation of the Impact upon Reaction Time and Sustained Attention
1
x
$
30.00
Metabolic and Endocrine Profiles During 1-Year Treatment of Outpatients with Schizophrenia with Aripiprazole Lauroxil
1
x
$
0.00
Test of Treatment in Psychiatric Practice by Feras Ali Mustafa
1
x
$
30.00
Agomelatine for Depression in Schizophrenia by Jochen Mutschler
1
x
$
30.00
View Cart
Checkout
Home
Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders
“Agomelatine for Depression in Schizophrenia by Jochen Mutschler” has been added to your cart.
View cart
Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders
$
30.00
Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 36 No. 4 Articles
Tags:
antidepressant
,
bipolar-disorder
,
carlos-a-zarate
,
depression
,
felbamate
,
glutamate
,
husseini-k-manji
,
jennifer-payne
,
jorge-quiroz
,
medworks-media
,
memantine
,
mood-stabilizer
,
nmdaampakainate
,
psychopharmacology-bulletin
,
riluzole
Description
Description
Carlos A. Zarate, MD
TRANSLATIONAL NEUROSCIENCE
Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders
Carlos A. Zarate, MD, Jorge Quiroz, MD, Jennifer Payne, MD, and Husseini K. Manji, MD
Related products
Zonisamide for Bipolar Depression by Deborah Dauphinais
$
30.00
Add to cart
Details
What Mood Symptoms may be most Difficult to Rate?
$
30.00
Add to cart
Details
Zonisamide for Bipolar Disorder, Mania or Mixed States by Deborah Dauphinais
$
30.00
Add to cart
Details
Test of Treatment in Psychiatric Practice by Feras Ali Mustafa
$
30.00
Add to cart
Details
Page load link
Go to Top